The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.

Li, Juan

The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2. [electronic resource] - Cancer letters Sep 2013 - 237-47 p. digital

Publication Type: Journal Article

1872-7980

10.1016/j.canlet.2013.05.006 doi


Animals
Antineoplastic Agents--immunology
Antineoplastic Agents, Alkylating--pharmacology
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Atrophy
B7-2 Antigen--metabolism
Cyclophosphamide--pharmacology
Drug Synergism
Histocompatibility Antigens Class I--metabolism
Hydrocortisone--pharmacology
Immunologic Factors--metabolism
Immunosuppressive Agents--pharmacology
Interferon-gamma--blood
Male
Melanoma, Experimental--drug therapy
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Protein Binding
Skin Neoplasms--drug therapy
Surface Plasmon Resonance
Thymalfasin
Thymocytes--drug effects
Thymopentin--immunology
Thymosin--analogs & derivatives
Thymus Gland--drug effects
Time Factors
Toll-Like Receptor 2--metabolism
Tumor Burden--drug effects